The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365, 260, a Central Cholecystokinin Receptor Antagonist, in Patients with Panic Disorder

Archives of General Psychiatry

Volumn 51, Issue 6, 1994, Pages 486-493

  Bradwejn, Jacques ^a   Koszycki, Diana ^a   Tertre, Anne Couëtoux ^a   van Megen, Harold ^b   den Boer, Johan ^b   Westenberg, Herman ^b   Annable, Lawrence ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; BRAIN RECEPTOR; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; PLACEBO; TETRAGASTRIN;

ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PANIC; RANDOMIZED CONTROLLED TRIAL; RECEPTOR BLOCKING; SYMPTOMATOLOGY;

ADMINISTRATION, ORAL; ADULT; BENZODIAZEPINONES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ANTAGONISM; FEMALE; HEART RATE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PANIC DISORDER; PHENYLUREA COMPOUNDS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; RECEPTORS, CHOLECYSTOKININ; SEVERITY OF ILLNESS INDEX; TETRAGASTRIN;

EID: 0028237882     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1994.03950060050005     Document Type: Article

References (52)

1. Uhde TW, Tancer ME. Chemical models of panic: a review and critique. In: Tyer P, ed. Pharmacology of Anxiety. New York, NY: Oxford University Press; 1989: 109–131.
2. Nutt D, Lawson C. Panic attacks: a neurochemical overview of models and mechanisms. Br J Psychiatry. 1992;160: 165–178.
3. Beinfeld MC. Cholecystokinin in the central nervous system: a mini-review. Neuropeptide. 1983;3: 411–427.
4. Vanderhaegen J-J, Lofstra F, Vierendeels G, Gilles C, Deschepper C, Verbauck P. Cholecystokinin in the central nervous system and neurohypophysis. Peptides. 1981;2: 81–88.
5. Rehfeld JF. Neuronal cholecystokinin: one or multiple neurotransmitters? J Neurochem. 1985;44: 1–10.
6. Gorman JM, Liebowitz MR, Fyer AJ, Stein J. Neuro-anatomical hypothesis for panic disorder. Am J Psychiatry. 1989;146: 148–161.
7. Abelson JL, Nesse RM. Cholecystokinin-4 and panic. Arch Gen Psychiatry. 1990;47:395.
8. Van Megen HJGM, den Boer JA, Westenberg HGM, Haigh JRM, Traub M. Evidence of enhanced sensitivity for pentagastrin in panic disorder patients. Clin Neuropharmacol. 1992;15(suppl 1, part B):58B
9. Bradwejn J, Koszycki D, Meterissian G. Cholecystokinin tetrapeptide induces panic attacks in patients with panic disorder. Can J Psychiatry. 1990;35: 83–85.
10. Bradwejn J, Koszycki D. Comparison of CO2-induced panic attacks with cholecystokinin-induced panic attacks in panic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 1991;15: 237–239.
11. Bradwejn J, Koszycki D, Annable L, Couëtoux du Tertre A, Reines S, Karkanias C. A dose-ranging study of the behavioral and cardiovascular effects of CC Ktetrapeptide in panic disorder. Biol Psychiatry. 1992;32: 903–912.
12. Bradwejn J, Koszycki D, Payeur R, Bourin M, Borthwick H. Study of the replication of action of cholecystokinin in panic disorders. Am J Psychiatry. 1992;149: 962–964.
13. Bradwejn J, Koszycki D, Shriqui C. Enhanced sensitivity to cholecystokinintetrapeptide in panic disorder: clinical and behavioral findings. Arch Gen Psychiatry. 1991;48: 603–607.
14. Bradwejn J, Koszycki D. CCK4 and panic attacks in man. In: Iversen S, Dourish C, Cooper F. eds. Multiple Cholecystokinin Receptors in Man. New York, NY: Oxford University Press; 1992: 121–131.
15. Bradwejn J, Koszycki D, Bourin M. Dose ranging study of the effect of CCK4 in healthy volunteers. J Psychiatry Neurosci. 1991;16: 260–264.
16. Bradwejn J, Koszycki D. Imipramine antagonizes the panicogenic effects of CCK-4 in panic disorder patients. Am J Psychiatry. 1994;151: 261–263.
17. Moran TH, Robinson PH, Goldrich MS, McHugh PR. Two brain cholecystokinin receptors: implications for behavioral actions. Brain Res. 1986;362: 175–179.
18. Dourish CT, Hill DR. Classification and function of CCK receptors. Trends Pharmacol Sci. 1987;8: 207–208.
19. Hill DR, Campbell NJ, Shaw TM, Woodruff GN. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective non-peptide CCK agonists. J Neurosci. 1987;7: 2967–2976.
20. Zarbin MA, Innis RB, Wamsley JK, Snyder SH, Kuhar MJ. Autoradiographic localization of cholecystokinin receptors in rodent brain. J Neurosci. 1983;3: 877–906.
21. Martinez J, Rodriguez M, Lignon MF. Cholecystokinin receptor antagonist. In: Wang RY, Schoenfeld RC, eds. Cholecystokinin Antagonists. New York, NY: Alan R. Liss Inc; 1988: 29–51.
22. Freidinger RM. Cholecystokinin and gastrin antagonists. Med Res Rev. 1989;9: 271–290.
23. Woodruff G, Hughes J. Cholecystokinin antagonists. Ann Rev Pharmacol Toxicol. 1991;31: 469–501.
24. Howbert JJ, Lobb KL, Brown RF. A novel series of non-peptide CCK and gastrin antagonists: medicinal chemistry and electrophysiological demonstration of antagonism. In: Iversen S, Dourish C, Cooper F, eds. Multiple Cholecystokinin Receptors in Man. New York, NY: Oxford University Press; 1992: 28–37.
25. Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DF, Anderson PS, Freidinger RM. Benzodiazepine gastrin and brain cholecystokinin receptor ligands: L-365, 260. J Med Chem. 1989;32: 13–16.
26. Harro J, Vasar E. Evidence that CCKB receptors mediate the regulation of exploratory behaviour in the rat. Eur J Pharmacol. 1991;193: 379–381.
27. Singh L, Lewis AS, Field MJ, Hughes J, Woodruff GN. Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc Natl Acad Sci USA. 1991;88: 1130–1133.
28. Cockran WG, Cox GM. Experimental Designs. 2nd ed. New York, NY: John Wiley & Sons Inc; 1957.
29. SAS Institute Inc. SAS/STAT Guide For Personal Computers, Version 6 Edition. Cary, NC: SAS Institute Inc; 1987.
30. Grizzle JE, Starmer CF, Koch GG. Analysis of categorical data by linear models. Biometrics. 1969;25: 489–504.
31. Palmour RE, Ervin FR, Bradwejn J, Howbert JJ. The anxiogenic and cardiovascular effects of CCKA are blocked by the CCKB antagonist LY262, 691. Abstracts of the 21th Annual Meeting of the Society for Neuroscience. Washington, DC: Society for Neuroscience; 1991:1602.
32. Rataud J, Darche F, Piot O, Stutzmann JM, Bohme GA, Blanchard JC. “Anxiolytic” effect of CCK-antagonists on plus-maze behaviour in mice. Brain Res. 1991;548: 315–317.
33. Takagi H, Kubota Y, Mori S, Tateishi K, Hamaoka T, Tohyama M. Fine structural studies of cholecystokinin-8—like immunoreactive neurons and axon terminals in the nucleus tractus solitarius of the rat. J Comp Neurol. 1984;227: 369–379.
34. Mantyh PW, Hunt SP. Evidence for cholecystokinin-like immunoreactive neurons in the rat medulla oblongata which project to the spinal cord. Brain Res. 1984;291: 49–54.
35. Harro J, Vasar E, Bradwejn J. Cholecystokinin in animal and human research on anxiety. Trends Pharmacol Sci. 1993;14: 244–249.
36. Chan SHH, Chan JYH, Ong BG. Anatomic connections between nucleus reticularis rostroventrolateralis and some medullary cardiovascular sites in the rat. Neurosci Lett. 1986;71: 277–282.
37. Dampney RAL, Goodchild AK, Robertson LG, Montgomery W. Role of ventrolateral medulla in vasomotor regulation: a correlative anatomical and physiological study. Brain Res. 1982;249: 223–235.
38. Dampney RAL, Czachurski J, Dembowsky K, Goodchild AK, Seller H. Afferent connections and spinal projections of the pressor region in the rostral ventrolateral medulla of the cat. J Auton Nerv Syst. 1922;20: 73–86.
39. Jordan D, Spyer KM. Brainstem integration of cardiovascular and pulmonary afferent activity. Prog Brain Res. 1986;67: 295–314.
40. Kirchheim HR. Systematic arterial baroreceptor reflexes. Physiol Rev. 1976;56: 100–176.
41. Spyer KM. Neural organization and control of the baroreceptor reflex. Rev Physiol Biochem Pharmacol. 1981;88: 23–124.
42. Ross CA. Ruggiero DA, Park DH, Joh TH, Sved AF, Fernandez-Pardal J, Saaverda JM, Reis DJ. Tonic vasomotor control by the rostral ventrolateral medulla: effect of electrical or chemical stimulation of the area containing C1 adrenaline neurons on arterial pressure, heart rate, and plasma catecholamines and vasopressin. J Neurosci. 1984;4: 474–494.
43. Pilowsky R, West M, Chalmers J. Renal sympathetic nerve responses to stimulation, inhibition and destruction of the ventrolateral medulla in the rabbit. Neurosci Lett. 1985;60: 51–55.
44. Gootman PR, Cohen MI. Evoked splanchnic potentials produced by electrical stimulation of medullary vasomotor regions. Exp Brain Res. 1971;13: 1–14.
45. Adair JR, Hamilton BL, Scappaticci KA, Helke CJ, Gillis RA. Cardiovascular responses to electrical stimulation of the medullary raphe area of the cat. Brain Res. 1977;128: 141–145.
46. Futuro-Neto HA, Coote JH. Desynchronized sleep-like pattern of sympathetic activity elicited by electrical stimulation of sites in the brainstem. Brain Res. 1982;252: 269–276.
47. Marovitch S, Kumada M, Reis DJ. Role of parabrachialis in cardiovascular regulation in the cat. Brain Res. 1982;232: 57–75.
48. Denavit-Saubié M, Hurlé MA, Morin-Surun MP, Foutz AS, Champagnat J. The effects of cholecystokinin-8 in the nucleus tractus solitarius. In: Vanderhaeghen JJ, Crawley JN, eds. Neuronal Cholecystokinin. New York: The New York Academy of Sciences; 1985: 375–384.
49. Ervin F, Palmour R, Bradwejn J. A new primate model for PD. In:American Psychiatric Association 144th Annual Meeting New Research Abstracts. New Orleans, La: American Psychiatric Association; 1991:100.
50. Harro J, Kiivet RA, Lang A, Vasar E. Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics. Behav Brain Res. 1990;39: 63–71.
51. Harro J, Pold M, Vasar E. Anxiogenic-like action of caerulein, a CCK-8 receptor agonist, in the mouse: influence of acute and subchronic diazepam treatment. Naunyn Schmidebergs Arch Pharmacol. 1990;341: 62–67.
52. Harro J, Marcusson J, Oreland L. Alterations in brain cholecystokinin receptors in suicide victims. Eur Neuropsychopharmacol. 1992;2: 57–63.